Display options
Share it on

J Clin Transl Endocrinol Case Rep. 2022 Mar;23:100104. doi: 10.1016/j.jecr.2021.100104. Epub 2021 Dec 17.

A case report of new onset graves' disease induced by SARS-CoV-2 infection or vaccine?.

Journal of clinical and translational endocrinology case reports

Walid Hamouche, Yahya El Soufi, Saleh Alzaraq, Belonwu Valentine Okafor, Fan Zhang, Christos Paras

Affiliations

  1. Internal Medicine Department, Brookdale University Hospital Medical Center, 1 Brookdale Plaza, Brooklyn, NY, USA.
  2. Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
  3. Faculty of Medicine, Jordan University of Science and Technology, Amman, Jordan.
  4. Nnmadi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
  5. Division of Endocrinology, Diabetes & Metabolism, Brookdale University Hospital Medical Center, 1 Brookdale Plaza, Brooklyn, NY, USA.
  6. Division of Endocrinology, Diabetes & Metabolism, State University of New York, Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY, USA.

PMID: 34934633 PMCID: PMC8679515 DOI: 10.1016/j.jecr.2021.100104

Abstract

The virus responsible for the COVID-19 pandemic continues to pose unmatched challenges in the world. It can cause systemic inflammation, which can lead to multiorgan involvement and subsequent damage. The relationship that possibly exists between the COVID-19 infection, the newly developed vaccines, and thyroid disease are still under extensive investigation. We are reporting the first case of new-onset graves' disease in a young, healthy man after COVID-19 infection and receiving a COVID-19 vaccine dose.

© 2021 The Authors.

Keywords: COVID-19; Graves' disease; Hyperthyroidism; Vaccine

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. J Endocrinol Invest. 2020 Aug;43(8):1171-1172 - PubMed
  2. Autoimmun Rev. 2021 Apr;20(4):102792 - PubMed
  3. Eur J Endocrinol. 2000 Mar;142(3):231-5 - PubMed
  4. Am J Med. 1992 Jul;93(1):61-8 - PubMed
  5. J Transl Med. 2019 Jan 7;17(1):11 - PubMed
  6. Immunol Res. 2017 Feb;65(1):55-65 - PubMed
  7. Front Endocrinol (Lausanne). 2017 Jan 24;7:150 - PubMed
  8. J Endocrinol Invest. 2020 Aug;43(8):1173-1174 - PubMed
  9. Clin Case Rep. 2021 Jun 17;9(6):e04225 - PubMed
  10. Thyroid. 2016 Oct;26(10):1343-1421 - PubMed
  11. Horm Metab Res. 2018 Dec;50(12):853-862 - PubMed
  12. Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):381-386 - PubMed
  13. J Endocrinol Invest. 2020 Oct;43(10):1527-1528 - PubMed
  14. J Endocrinol Invest. 1995 Dec;18(11):857-61 - PubMed
  15. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926-e935 - PubMed
  16. Endocrine. 2021 Aug;73(2):243-254 - PubMed
  17. Best Pract Res Clin Endocrinol Metab. 2020 Jan;34(1):101412 - PubMed
  18. Physiol Rev. 2014 Apr;94(2):355-82 - PubMed
  19. J Clin Endocrinol Metab. 2020 Jul 1;105(7): - PubMed
  20. Thyroid. 2021 Sep;31(9):1436-1439 - PubMed

Publication Types